Objectives
To assess the change in clinical status of patients with generalized myasthenia gravis treated with thymectomy and to identify prognostic variables that may be of significance in optimizing patient selection.
Design
Retrospective review. Mean follow-up period was 41 months.
Setting
Large community hospital.
Patients
Thirty-seven patients (11 male and 26 female) with generalized myasthenia gravis who were referred for thymectomy if they were refractory to medical treatment or had a thymoma. This represents all patients undergoing thymectomy for myasthenia gravis between January 1982 and December 1991.
Interventions
Each patient underwent staging before and after thymectomy using a modified Osserman classification. Medication requirements were also recorded. All patients underwent transsternal thymectomy and complete mediastinal dissection.
Main Outcome Measures
Changes in clinical stage and medication requirement before and after thymectomy; effect of patient age, sex, duration of disease, stage of disease, antibody status, histologic characteristics of the thymus, and duration of follow-up on outcome.
Results
Improvement after thymectomy was noted in all 37 patients. Complete remission was achieved in three patients (8%) and pharmacologic remission in 23 (62%). The remainder improved in stage, medication requirement, or both. Patients in preoperative stages lib and IIc showed the greatest improvement. Age, sex, duration of disease, antibody status, histologic characteristics of the thymus, and duration of follow-up were not significant factors in assessing improvement.
Conclusions
Transsternal thymectomy was found to be beneficial to all patients with generalized myasthenia gravis. Complete or pharmacologic remission was achieved in most patients (70%) following the procedure. Patients in preoperative stages lib and IIc showed the greatest degree of postoperative improvement.
(Arch Surg. 1993;128:855-862)
Plasmapheresis before thymectomy in myasthenia gravis: routine versus selective protocols
El-Bawab et al.
Eur. J. Cardiothorac. Surg. 2009;35:392-397.
ABSTRACT
| FULL TEXT
The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy
Mori et al.
J. Thorac. Cardiovasc. Surg. 2007;133:364-368.
ABSTRACT
| FULL TEXT
Outcomes After 151 Extended Transcervical Thymectomies for Myasthenia Gravis
Shrager et al.
Ann. Thorac. Surg. 2006;82:1863-1869.
ABSTRACT
| FULL TEXT
Thymoma: Benign Appearance, Malignant Potential
Riedel and Burfeind
The Oncologist 2006;11:887-894.
ABSTRACT
| FULL TEXT
Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy
Shrager et al.
Ann. Thorac. Surg. 2002;74:320-327.
ABSTRACT
| FULL TEXT
Video-Assisted Thoracoscopic Thymectomy in Juvenile Myasthenia Gravis
Kolski et al.
J Child Neurol 2001;16:569-573.
ABSTRACT
Extended thymectomy in myasthenia gravis: a team-work of neurologist, thoracic surgeon and anaesthesist may improve the outcome
Mussi et al.
Eur. J. Cardiothorac. Surg. 2001;19:570-575.
ABSTRACT
| FULL TEXT
Continuous Neostigmine Infusion in Post-Thymectomy Juvenile Myasthenic Crisis
Briassoulis et al.
J Child Neurol 2000;15:747-749.
ABSTRACT
Thymoma: State of the Art
Thomas et al.
JCO 1999;17:2280-2280.
ABSTRACT
| FULL TEXT
Efficacy and safety of extended thymectomy for elderly patients with myasthenia gravis
Tsuchida et al.
Ann. Thorac. Surg. 1999;67:1563-1567.
ABSTRACT
| FULL TEXT
Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases
Nieto et al.
Ann. Thorac. Surg. 1999;67:1568-1571.
ABSTRACT
| FULL TEXT
One Hundred Consecutive Thymectomies for Myasthenia Gravis
Detterbeck et al.
Ann. Thorac. Surg. 1996;62:242-245.
ABSTRACT
| FULL TEXT
